Titre : Épilepsies myocloniques

Épilepsies myocloniques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Ganoderma
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Épilepsies myocloniques : Questions médicales les plus fréquentes", "headline": "Épilepsies myocloniques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Épilepsies myocloniques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-27", "dateModified": "2025-04-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Épilepsies myocloniques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Syndromes épileptiques", "url": "https://questionsmedicales.fr/mesh/D000073376", "about": { "@type": "MedicalCondition", "name": "Syndromes épileptiques", "code": { "@type": "MedicalCode", "code": "D000073376", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.228.140.490.493" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Épilepsies myocloniques progressives", "alternateName": "Myoclonic Epilepsies, Progressive", "url": "https://questionsmedicales.fr/mesh/D020191", "about": { "@type": "MedicalCondition", "name": "Épilepsies myocloniques progressives", "code": { "@type": "MedicalCode", "code": "D020191", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.228.140.490.493.063.650" } } }, { "@type": "MedicalWebPage", "name": "Épilepsie myoclonique juvénile", "alternateName": "Myoclonic Epilepsy, Juvenile", "url": "https://questionsmedicales.fr/mesh/D020190", "about": { "@type": "MedicalCondition", "name": "Épilepsie myoclonique juvénile", "code": { "@type": "MedicalCode", "code": "D020190", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.228.140.490.493.063.670" } } } ], "about": { "@type": "MedicalCondition", "name": "Épilepsies myocloniques", "alternateName": "Epilepsies, Myoclonic", "code": { "@type": "MedicalCode", "code": "D004831", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Pasquale Striano", "url": "https://questionsmedicales.fr/author/Pasquale%20Striano", "affiliation": { "@type": "Organization", "name": "IRCCS Istituto \"Giannina Gaslini\", Genova, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy." } }, { "@type": "Person", "name": "Marte Syvertsen", "url": "https://questionsmedicales.fr/author/Marte%20Syvertsen", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Drammen Hospital, Vestre Viken Health Trust, Oslo, Norway." } }, { "@type": "Person", "name": "Deb K Pal", "url": "https://questionsmedicales.fr/author/Deb%20K%20Pal", "affiliation": { "@type": "Organization", "name": "Department of Basic & Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Jeanette Koht", "url": "https://questionsmedicales.fr/author/Jeanette%20Koht", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Drammen Hospital, Vestre Viken Health Trust, Oslo, Norway." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Hydrogen sulfide maintains mitochondrial homeostasis and regulates ganoderic acids biosynthesis by SQR under heat stress in Ganoderma lucidum.", "datePublished": "2024-06-06", "url": "https://questionsmedicales.fr/article/38865903", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.redox.2024.103227" } }, { "@type": "ScholarlyArticle", "name": "Heterologous expression and characterization of a dye-decolorizing peroxidase from Ganoderma lucidum, and its application in decolorization and detoxifization of different types of dyes.", "datePublished": "2024-08-17", "url": "https://questionsmedicales.fr/article/39153119", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11274-024-04084-x" } }, { "@type": "ScholarlyArticle", "name": "The transcription factor GCN4 contributes to maintaining intracellular amino acid contents under nitrogen-limiting conditions in the mushroom Ganoderma lucidum.", "datePublished": "2023-10-10", "url": "https://questionsmedicales.fr/article/37817159", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12934-023-02213-z" } }, { "@type": "ScholarlyArticle", "name": "Comparing Application Methods of Reishi Mushroom (Ganoderma lucidum) Extract in Deep-Fried Meatballs: Impact on Heterocyclic Aromatic Amine Formation.", "datePublished": "2024-02-26", "url": "https://questionsmedicales.fr/article/38407784", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jsfa.13414" } }, { "@type": "ScholarlyArticle", "name": "Structural clarification of mannoglucan GSBP-2 from Ganoderma sinense and its effects on triple-negative breast cancer migration and invasion.", "datePublished": "2024-04-28", "url": "https://questionsmedicales.fr/article/38688342", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijbiomac.2024.131903" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009422" }, { "@type": "ListItem", "position": 3, "name": "Maladies du système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002493" }, { "@type": "ListItem", "position": 4, "name": "Encéphalopathies", "item": "https://questionsmedicales.fr/mesh/D001927" }, { "@type": "ListItem", "position": 5, "name": "Épilepsie", "item": "https://questionsmedicales.fr/mesh/D004827" }, { "@type": "ListItem", "position": 6, "name": "Syndromes épileptiques", "item": "https://questionsmedicales.fr/mesh/D000073376" }, { "@type": "ListItem", "position": 7, "name": "Épilepsies myocloniques", "item": "https://questionsmedicales.fr/mesh/D004831" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Épilepsies myocloniques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Épilepsies myocloniques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Épilepsies myocloniques", "description": "Comment diagnostiquer une épilepsie myoclonique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent une épilepsie myoclonique ?\nL'épilepsie myoclonique est-elle héréditaire ?\nQuel rôle joue l'EEG dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Ganoderma&page=17#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Épilepsies myocloniques", "description": "Quels sont les symptômes principaux ?\nLes myoclonies sont-elles douloureuses ?\nPeut-on avoir des crises sans myoclonies ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLes crises peuvent-elles survenir la nuit ?", "url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Ganoderma&page=17#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Épilepsies myocloniques", "description": "Peut-on prévenir les crises myocloniques ?\nQuels déclencheurs sont à éviter ?\nL'éducation est-elle importante pour la prévention ?\nLe suivi médical est-il essentiel ?\nLes activités physiques sont-elles sûres ?", "url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Ganoderma&page=17#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Épilepsies myocloniques", "description": "Quels médicaments sont utilisés pour traiter ?\nY a-t-il des traitements non médicamenteux ?\nComment évaluer l'efficacité du traitement ?\nLes traitements sont-ils à vie ?\nQuels effets secondaires des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Ganoderma&page=17#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Épilepsies myocloniques", "description": "Quelles complications peuvent survenir ?\nL'épilepsie myoclonique peut-elle affecter la vie quotidienne ?\nY a-t-il un risque accru de dépression ?\nLes crises peuvent-elles entraîner des accidents ?\nComment gérer les complications psychologiques ?", "url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Ganoderma&page=17#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Épilepsies myocloniques", "description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque d'épilepsie myoclonique ?\nLes troubles neurologiques augmentent-ils le risque ?\nLe stress est-il un facteur de risque ?\nLes infections cérébrales sont-elles un risque ?", "url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Ganoderma&page=17#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une épilepsie myoclonique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique médical, l'examen neurologique et l'EEG." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'EEG, l'IRM cérébrale et des tests sanguins peuvent être utilisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une épilepsie myoclonique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des secousses musculaires rapides, souvent sans perte de conscience, sont typiques." } }, { "@type": "Question", "name": "L'épilepsie myoclonique est-elle héréditaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Certaines formes peuvent être héréditaires, nécessitant une évaluation familiale." } }, { "@type": "Question", "name": "Quel rôle joue l'EEG dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'EEG aide à détecter les anomalies électriques typiques des épilepsies myocloniques." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des myoclonies, des crises généralisées et parfois des absences." } }, { "@type": "Question", "name": "Les myoclonies sont-elles douloureuses ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les myoclonies ne sont généralement pas douloureuses, mais peuvent être gênantes." } }, { "@type": "Question", "name": "Peut-on avoir des crises sans myoclonies ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent avoir des crises généralisées sans myoclonies." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la fréquence des symptômes peuvent varier considérablement." } }, { "@type": "Question", "name": "Les crises peuvent-elles survenir la nuit ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des crises myocloniques peuvent survenir pendant le sommeil." } }, { "@type": "Question", "name": "Peut-on prévenir les crises myocloniques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par un traitement adéquat et l'évitement des déclencheurs." } }, { "@type": "Question", "name": "Quels déclencheurs sont à éviter ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, la fatigue, et la consommation d'alcool peuvent déclencher des crises." } }, { "@type": "Question", "name": "L'éducation est-elle importante pour la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation sur la maladie aide les patients à mieux gérer leur condition." } }, { "@type": "Question", "name": "Le suivi médical est-il essentiel ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes." } }, { "@type": "Question", "name": "Les activités physiques sont-elles sûres ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines activités peuvent être sûres, mais il faut éviter les sports à risque." } }, { "@type": "Question", "name": "Quels médicaments sont utilisés pour traiter ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les anticonvulsivants comme le valproate et le lamotrigine sont couramment prescrits." } }, { "@type": "Question", "name": "Y a-t-il des traitements non médicamenteux ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme la thérapie comportementale et la diététique peuvent aider." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité du traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par la réduction des crises et les effets secondaires." } }, { "@type": "Question", "name": "Les traitements sont-ils à vie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Souvent, le traitement est à long terme, mais certains peuvent réduire ou arrêter." } }, { "@type": "Question", "name": "Quels effets secondaires des médicaments ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure fatigue, vertiges et troubles gastro-intestinaux." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des blessures dues aux crises et des troubles psychologiques." } }, { "@type": "Question", "name": "L'épilepsie myoclonique peut-elle affecter la vie quotidienne ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut impacter la vie sociale, professionnelle et la qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de dépression ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes épileptiques ont un risque plus élevé de dépression et d'anxiété." } }, { "@type": "Question", "name": "Les crises peuvent-elles entraîner des accidents ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les crises peuvent provoquer des accidents, notamment lors de la conduite." } }, { "@type": "Question", "name": "Comment gérer les complications psychologiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un soutien psychologique et des thérapies adaptées peuvent aider à gérer ces complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, les traumatismes crâniens et certaines infections sont des facteurs." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'épilepsie myoclonique ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'épilepsie myoclonique peut débuter à tout âge, mais souvent dans l'enfance ou l'adolescence." } }, { "@type": "Question", "name": "Les troubles neurologiques augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, d'autres troubles neurologiques peuvent augmenter le risque d'épilepsie myoclonique." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut déclencher des crises chez les personnes prédisposées." } }, { "@type": "Question", "name": "Les infections cérébrales sont-elles un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections, comme la méningite, peuvent augmenter le risque d'épilepsie." } } ] } ] }

Sources (195 au total)

Heterologous expression and characterization of a dye-decolorizing peroxidase from Ganoderma lucidum, and its application in decolorization and detoxifization of different types of dyes.

Dye-decolorizing peroxidases (DyPs) belong to a novel superfamily of heme peroxidases that can oxidize recalcitrant compounds. In the current study, the GlDyP2 gene from Ganoderma lucidum was heterolo...

The transcription factor GCN4 contributes to maintaining intracellular amino acid contents under nitrogen-limiting conditions in the mushroom Ganoderma lucidum.

Edible mushrooms are delicious in flavour and rich in high-quality protein and amino acids required by humans. A transcription factor, general control nonderepressible 4 (GCN4), can regulate the expre... In this study, we found that the amino acid contents reached 120.51 mg per gram of mycelia in the WT strain under 60 mM asparagine (Asn) conditions, but decreased by 62.96% under 3 mM Asn conditions. ... This study confirmed that GCN4 contributes to maintaining the amino acid contents in mushrooms under low concentrations of nitrogen. In conclusion, our study provides a research basis for GCN4 to regu...

Comparing Application Methods of Reishi Mushroom (Ganoderma lucidum) Extract in Deep-Fried Meatballs: Impact on Heterocyclic Aromatic Amine Formation.

The present research was conducted to investigate the impact of reishi mushroom extract (RME) on the formation of heterocyclic aromatic amines (HAAs) in meatballs. Sample preparations involved applyin... The types and levels of HAAs varied based on the frying temperature, method of extract application, and the extract concentration. Notably, total HAA contents increased with rising the frying temperat... This study demonstrated that RME had mitigating effects on HAAs depending on the concentration and frying conditions in deep-fried meatball samples. This article is protected by copyright. All rights ...

Efficient and fast screening and separation based on computer-aided screening and complex chromatography methods for lipoxygenase inhibitors from Ganoderma lucidum.

Accurate screening and targeted preparative isolation of active substances from natural medicines have long been technical challenges in natural medicine research.... This study outlines a new approach for improving the efficiency of natural product preparation, focusing on the rapid and accurate screening of potential active ingredients in Ganoderma lucidum and ef... The medicinal plant G. lucidum was selected through ultrafiltration coupled with liquid chromatography and mass spectrometry (UF-LC-MS) and computer-assisted screening for lipoxygenase (LOX) inhibitor... Five active ingredients, ganoderic acids A, B, C... The innovative methods of UF-LC-MS, computer-aided screening, and complex chromatography provide powerful tools for screening and separating LOX inhibitors from complex matrices and provide a favourab...

Deciphering the chemical composition of Ganoderma lucidum from different geographical origins by mass spectrometry molecular networking coupled with multivariate analysis.

Ganoderma lucidum is a medicinal fungus that has been widely used in China and many Asian countries for thousands of years. This once rare macrofungus has now been artificially cultivated in a number ...

Use of mushrooms as antioxidants in lipid oxidation model under indirect and direct oxidation test: Ethanolic extracts of Ganoderma resinaceum and Phlebopus bruchii.

Foods contain lipids that are easily susceptible to oxidation, which can modify their sensory properties. While these compounds provide characteristic flavours and odours, but unwanted compounds, such... The composition profile of the extracts was investigated, identifying the presence of tryptophan, quinic acid, caffeic acid, and 3,4-DHPG. The antioxidant capacity of the extracts was compared to that... Based on these results, both extracts could be proposed as potential antioxidants in foods with high lipid content. This article is protected by copyright. All rights reserved....